The Public Has Been Forgiving. But Hospitals Got Some Things Wrong.
Mistakes are inevitable. But we can try to do better. More
Mistakes are inevitable. But we can try to do better. More
Maine investigators find one patient’s saga with O’NA HealthCare offers a cautionary tale for anyone looking for cut-rate coverage online. More
Two top FDA officials will recuse themselves from Covid-19 vaccine approval decisions since they are joining a Trump push for approval. More
Remdesivir is the poster child for why we need a new model of drug development for pandemics and neglected diseases that isn't market-based. More
Congress authorized $100 billion for health care providers, both to compensate them for the extra costs associated with caring for patients with COVID-19 and for the revenue that’s not coming in from regular care. They have been required to stop providing most nonemergency services, and many patients are afraid to visit health care facilities. More
Bedaquiline, an important treatment for tuberculosis, costs too much for most people. Johnson & Johnson could sell it for $1 a day and still turn a profit. More
Allergan’s “medical aesthetics” products helped persuade AbbVie to buy the company. But what if the devices driving profit are also endangering women’s health? More
Surgeries are canceled. Business models are shifting. Some of the hardest-hit hospitals may close, leaving patients with fewer options for care. More
After years of undermining health policy to aid their Big Pharma patrons, patient advocacy groups are making claims to federal pandemic relief. More
The disconnect between hospital policy and worker expectations often centers around the lack of clear, direct communication with individual workers who have been potentially exposed to the coronavirus. More
Hospitals have been sharing supplies, equipment, data, and even staff as they scramble to treat patients sick with COVID-19, the disease caused by the coronavirus. More
Administrators across the country are increasingly turning to anti-labor consultants to fend off nurses’ unions. More
As losses mount, hospital chains like Advocate Aurora Health, Providence and Loyola Medicine have had to trim costs—including at the top. More
This Viewpoint describes how the clinical decision support tools that are part of electronic health records and are used by physicians may be corrupted by commercial influence. More
Florida Cancer Specialists said that coronavirus relief dollars from taxpayers will not be used to pay back their fines. More
Faced with lost revenue from canceled elective procedures, hospitals laid off 1.4 million health care workers in April, including nearly 135,000 from hospitals. More
The pharmaceutical industry often justifies high drug prices by claiming that they create more innovation, but two recent studies find that drug costs and clinical benefit are often not related. More
Structural racism created the unequal conditions driving the black-white health gap. Disparities in COVID-19 infection and death rates show just how dire that gap is. More
Despite the direct and personal care that nurses provide, they are not valued as they should be. That's a shame, and maybe even a deadly shame. More
The financial burdens and subsequent related distress of medical care, referred to as financial toxicity, may limit access to beneficial treatments. More